BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28644307)

  • 1. X-linked Sideroblastic Anemia in a Malay Boy With ALAS2 S568G Mutation.
    Susanto TAK; Bhattacharyya R
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):408-409. PubMed ID: 28644307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation Analysis of X-linked Sideroblastic Anemia in a 12-Month-Old Boy by Massively Parallel Sequencing.
    Yu HJ; Lee YJ; Shim JW; Kim DS; Shim JY; Park MS; Woo HY; Park H; Jung HL; Kwon MJ
    Ann Lab Med; 2018 Jul; 38(4):389-392. PubMed ID: 29611395
    [No Abstract]   [Full Text] [Related]  

  • 3. A Novel
    Lee JS; Gu J; Yoo HJ; Koh Y; Kim HK
    Ann Clin Lab Sci; 2017 May; 47(3):319-322. PubMed ID: 28667034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double red cells population in a woman with a microcytic anemia.
    Garçon L; Kannengiesser C
    Blood; 2014 Feb; 123(6):808. PubMed ID: 24660232
    [No Abstract]   [Full Text] [Related]  

  • 5. A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia.
    Bekri S; May A; Cotter PD; Al-Sabah AI; Guo X; Masters GS; Bishop DF
    Blood; 2003 Jul; 102(2):698-704. PubMed ID: 12663458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation, Ile289Thr, in the ALAS2 gene in a family with pyridoxine responsive sideroblastic anaemia.
    Percy MJ; Cuthbert RJ; May A; McMullin MF
    J Clin Pathol; 2006 Sep; 59(9):1002. PubMed ID: 16935983
    [No Abstract]   [Full Text] [Related]  

  • 7. Lethal ALAS2 mutation in males X-linked sideroblastic anaemia.
    Rose C; Callebaut I; Pascal L; Oudin C; Fournier M; Gouya L; Lambilliotte A; Kannengiesser C
    Br J Haematol; 2017 Aug; 178(4):648-651. PubMed ID: 27292130
    [No Abstract]   [Full Text] [Related]  

  • 8. Late-onset X-linked sideroblastic anemia following hemodialysis.
    Furuyama K; Harigae H; Kinoshita C; Shimada T; Miyaoka K; Kanda C; Maruyama Y; Shibahara S; Sassa S
    Blood; 2003 Jun; 101(11):4623-4. PubMed ID: 12531813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raab SO, Haut A, Cartwright GE, Wintrobe MM. Pyridoxine-responsive anemia. Blood. 1961;18(3):285-302.
    Blood; 2016 May; 127(20):2365. PubMed ID: 27207318
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case report of X-linked sideroblastic anemia with novel ALAS2 gene mutation].
    Bao SJ; Zhu HM; Tong Y; Hao D; Ling Y; Yuan W; Zhou Y; Sun ZQ
    Zhonghua Xue Ye Xue Za Zhi; 2019 Aug; 40(8):684. PubMed ID: 31495138
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel mutations in the ALAS2 gene from patients with X-linked sideroblastic anemia.
    Li J; Chen L; Lin Y; Ru K
    Int J Lab Hematol; 2020 Aug; 42(4):e160-e163. PubMed ID: 32297424
    [No Abstract]   [Full Text] [Related]  

  • 12. X-linked sideroblastic anemia associated with a novel ALAS2 mutation and unfortunate skewed X-chromosome inactivation patterns.
    Aivado M; Gattermann N; Rong A; Giagounidis AA; Prall WC; Czibere A; Hildebrandt B; Haas R; Bottomley SS
    Blood Cells Mol Dis; 2006; 37(1):40-5. PubMed ID: 16735131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyridoxine-sensitive X-linked 'sideroblastic' anaemia in the absence of ring sideroblasts - molecular diagnosis.
    Creasey T; Biss T; Lambert J; Smith F; Clark B; Carey P
    Br J Haematol; 2018 Jan; 180(1):10. PubMed ID: 29105823
    [No Abstract]   [Full Text] [Related]  

  • 14. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine.
    Kucerova J; Horvathova M; Mojzikova R; Belohlavkova P; Cermak J; Divoky V
    Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females.
    Cazzola M; May A; Bergamaschi G; Cerani P; Rosti V; Bishop DF
    Blood; 2000 Dec; 96(13):4363-5. PubMed ID: 11110715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
    Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
    J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R411C mutation of the ALAS2 gene encodes a pyridoxine-responsive enzyme with low activity.
    Furuyama K; Uno R; Urabe A; Hayashi N; Fujita H; Kondo M; Sassa S; Yamamoto M
    Br J Haematol; 1998 Dec; 103(3):839-41. PubMed ID: 9858242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mutation of the erythroid-specific gamma-Aminolevulinate synthase gene in a patient with non-inherited pyridoxine-responsive sideroblastic anemia.
    Harigae H; Furuyama K; Kudo K; Hayashi N; Yamamoto M; Sassa S; Sasaki T
    Am J Hematol; 1999 Oct; 62(2):112-4. PubMed ID: 10577279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microcytic anemia in a pregnant woman: beyond iron deficiency.
    Rollón N; Fernández-Jiménez MC; Moreno-Carralero MI; Murga-Fernández MJ; Morán-Jiménez MJ
    Int J Hematol; 2015 May; 101(5):514-9. PubMed ID: 25547425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel hemizygous I418S mutation in the ALAS2 gene in a young Korean man with X-linked sideroblastic anemia.
    Moon SY; Jun IJ; Kim JE; Lee SJ; Kim HK; Yoon SS
    Ann Lab Med; 2014 Mar; 34(2):159-62. PubMed ID: 24624355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.